by The Zambia cholera vaccines market has been witnessing high growth over the past few years owing to growing awareness about water-borne diseases like cholera among the population. Cholera vaccines help prevent the spread of cholera by developing immunity in the individual. Being endemic to Zambia, cholera presents a huge public health challenge. The oral cholera vaccines target at-risk populations and are administered to both children and adults to curb outbreaks.
Zambia cholera vaccines market is estimated to be valued at US$ 1.47 million in 2024 and is expected to exhibit a CAGR of 14 % over the forecast period 2024 to 2031.
Cholera vaccines provide protection against severe dehydration and death from cholera. They help the body develop antibodies against cholera toxins without causing the disease. Oral vaccines are easy to administer and preferred for mass immunization campaigns. Rising cases of cholera deaths in the country owing to consumption of contaminated water is driving the demand for these vaccines. They are playing a key role in controlling endemic cholera and preventing outbreaks.
Key Takeaways
Key players operating in the Zambia cholera vaccines market are Biovac Inc., Valneva SE., EMERGENT, Astellas Pharma Inc, Sanofi, EUBIOLOGICS CO., LTD,Johnson & Johnson Services Inc., Celldex Therapeutics.
The market provides lucrative opportunities for vaccine manufacturers owing to growing government focus on preventive healthcare. Introduction of novel vaccines and vaccine combinations with higher efficacy can drive the uptake.
Rising global focus on safety and affordability of Zambia Cholera Vaccines Market Growth is encouraging their adoption in cholera endemic regions like Africa and Asia. UNICEF is working closely with manufacturers to ensure steady supply and distribution of vaccines.
Market Drivers
Growing awareness among citizens about the importance of hygiene and sanitation due to health campaigns is a key driver for this market. Non-governmental organizations are educating people about water treatment and cooking practices to prevent water-borne outbreaks. Rising disposable incomes is also encouraging people to adopt personal hygiene measures and vaccinations.
PEST Analysis
Political: The government focus on health and disease control, numerous initiatives to promote vaccination, and make vaccines available across the country positively influences the market. However, political instability and limited government budget allocation for health can hamper market growth.
Economic: Rising per capita income, improving healthcare infrastructure, growing awareness about health and preventive healthcare, and increasing disease burden supports market growth. However, poverty, unemployment can limiting factors for mass vaccination.
Social: Increasing awareness about vaccine-preventable diseases, growing health consciousness and health seeking behavior, improvement in literacy rate, healthcare access, and changing lifestyle are significant influencers.
Technological: Advancement in biotechnology, vaccine production technologies, cold chain logistics, and digital health solutions enables sustainable supply and improve access in remote areas. Connected health technologies will further aid market expansion.
The Zambia cholera vaccines market is highly concentrated in urban areas such as Lusaka Province and Copperbelt Province where healthcare infrastructure is relatively better developed. These regions account for over 60% of the total market value due to the availability of vaccination centers, trained healthcare personnel, and higher disease incidence compared to rural areas. Northern Province region is expected to register the fastest growth during the forecast period supported by infrastructure development projects around new mining centers, expanding urbanization, and government focus on improving sanitation and public health in the region.
The Zambia cholera vaccines market is presently dominated by Lusaka Province in terms of value which contributes around 35% to the total market share. This can be attributed to the presence of major healthcare facilities, local manufacturing units of key market players, and the domicile of over 30% of Zambia’s total population within Lusaka urban and peri-urban areas making vaccines highly accessible. Copperbelt Province holds the second largest market share supported by developed healthcare infrastructure around major mining districts and urban centers such as Ndola and Kitwe. However, Northern Province is identified as the fastest growing regional market for cholera vaccines driven by ongoing industry and infrastructure projects in mining and construction.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
